5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)
- 11 March 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (9) , 1581-1584
- https://doi.org/10.1016/s0960-894x(03)00135-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival PathwayJournal of Biological Chemistry, 1998
- Expression and characterization of glycogen synthase kinase-3 mutants and their effect on glycogen synthase activity in intact cells.Proceedings of the National Academy of Sciences, 1996
- Multiple mechanisms for the phosphorylation of C-terminal regulatory sites in rabbit muscle glycogen synthase expressed in COS cellsBiochemical Journal, 1996
- Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cellsCurrent Biology, 1994
- Insulin Resistance in Skeletal Muscles in Patients With NIDDMDiabetes Care, 1992
- Pathogenesis of NIDDM: A Balanced OverviewDiabetes Care, 1992
- Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.Journal of Clinical Investigation, 1990
- Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism.Journal of Clinical Investigation, 1987
- Correlation between muscle glycogen synthase activity and in vivo insulin action in man.Journal of Clinical Investigation, 1984
- Biosynthesis of glycogen from uridine diphosphate glucoseArchives of Biochemistry and Biophysics, 1959